CYNGN INC (CYN)

US23257B2060 - Common Stock

0.4689  -1.14 (-70.88%)

After market: 0.509 +0.04 (+8.55%)

Fundamental Rating

3

We assign a fundamental rating of 3 out of 10 to CYN. CYN was compared to 278 industry peers in the Software industry. CYN has a great financial health rating, but its profitability evaluates not so good. While showing a medium growth rate, CYN is valued expensive at the moment.



0

1. Profitability

1.1 Basic Checks

In the past year CYN has reported negative net income.
CYN had a negative operating cash flow in the past year.
In the past 5 years CYN always reported negative net income.
In the past 5 years CYN always reported negative operating cash flow.

1.2 Ratios

The Return On Assets of CYN (-266.17%) is worse than 97.84% of its industry peers.
With a Return On Equity value of -339.50%, CYN is not doing good in the industry: 85.61% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -266.17%
ROE -339.5%
ROIC N/A
ROA(3y)-94.96%
ROA(5y)-95.24%
ROE(3y)-109.77%
ROE(5y)-109.18%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

The Profit Margin and Operating Margin and Gross Margin are not available for CYN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

7

2. Health

2.1 Basic Checks

CYN does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for CYN has been reduced compared to 1 year ago.
CYN has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CYN has an Altman-Z score of -36.42. This is a bad value and indicates that CYN is not financially healthy and even has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -36.42, CYN is doing worse than 96.76% of the companies in the same industry.
There is no outstanding debt for CYN. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -36.42
ROIC/WACCN/A
WACC11.78%

2.3 Liquidity

A Current Ratio of 2.43 indicates that CYN has no problem at all paying its short term obligations.
The Current ratio of CYN (2.43) is better than 67.99% of its industry peers.
A Quick Ratio of 2.22 indicates that CYN has no problem at all paying its short term obligations.
CYN has a Quick ratio of 2.22. This is in the better half of the industry: CYN outperforms 66.91% of its industry peers.
Industry RankSector Rank
Current Ratio 2.43
Quick Ratio 2.22

4

3. Growth

3.1 Past

CYN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 56.18%, which is quite impressive.
Looking at the last year, CYN shows a very negative growth in Revenue. The Revenue has decreased by -94.01% in the last year.
EPS 1Y (TTM)56.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.43%
Revenue 1Y (TTM)-94.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.4%

3.2 Future

The Earnings Per Share is expected to grow by 24.80% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 151.86% on average over the next years. This is a very strong growth
EPS Next Y71.85%
EPS Next 2Y35.46%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue Next Year14.59%
Revenue Next 2Y143.68%
Revenue Next 3Y151.86%
Revenue Next 5YN/A

3.3 Evolution

1

4. Valuation

4.1 Price/Earnings Ratio

CYN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for CYN. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

CYN's earnings are expected to grow with 24.80% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.46%
EPS Next 3Y24.8%

0

5. Dividend

5.1 Amount

CYN does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CYNGN INC

NASDAQ:CYN (12/20/2024, 8:04:40 PM)

After market: 0.509 +0.04 (+8.55%)

0.4689

-1.14 (-70.88%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-06 2024-11-06/amc
Earnings (Next)N/A N/A
Inst Owners19.77%
Inst Owner Change-96.45%
Ins Owners144.59%
Ins Owner Change0%
Market Cap1.14M
Analysts83.33
Price Target157.72 (33536.17%)
Short Float %10.56%
Short Ratio0.31
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)36.52%
Min EPS beat(2)23.9%
Max EPS beat(2)49.13%
EPS beat(4)3
Avg EPS beat(4)10.5%
Min EPS beat(4)-32.01%
Max EPS beat(4)49.13%
EPS beat(8)7
Avg EPS beat(8)9.6%
EPS beat(12)8
Avg EPS beat(12)-44.1%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-95.93%
Min Revenue beat(2)-98.41%
Max Revenue beat(2)-93.44%
Revenue beat(4)0
Avg Revenue beat(4)-84.26%
Min Revenue beat(4)-98.48%
Max Revenue beat(4)-46.72%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.83%
PT rev (3m)-28.74%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-4475%
EPS NY rev (1m)0%
EPS NY rev (3m)48.84%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-29.71%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.29%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 11.16
P/FCF N/A
P/OCF N/A
P/B 0.17
P/tB 0.22
EV/EBITDA N/A
EPS(TTM)-26.85
EYN/A
EPS(NY)-9.7
Fwd EYN/A
FCF(TTM)-8.83
FCFYN/A
OCF(TTM)-8.47
OCFYN/A
SpS0.04
BVpS2.74
TBVpS2.12
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -266.17%
ROE -339.5%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-94.96%
ROA(5y)-95.24%
ROE(3y)-109.77%
ROE(5y)-109.18%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.01
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 93.09%
Cap/Sales 863.05%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.43
Quick Ratio 2.22
Altman-Z -36.42
F-Score2
WACC11.78%
ROIC/WACCN/A
Cap/Depr(3y)109.6%
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)56.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%80.43%
EPS Next Y71.85%
EPS Next 2Y35.46%
EPS Next 3Y24.8%
EPS Next 5YN/A
Revenue 1Y (TTM)-94.01%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%90.4%
Revenue Next Year14.59%
Revenue Next 2Y143.68%
Revenue Next 3Y151.86%
Revenue Next 5YN/A
EBIT growth 1Y4.05%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year14.99%
EBIT Next 3Y26.89%
EBIT Next 5YN/A
FCF growth 1Y-40.87%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-41.4%
OCF growth 3YN/A
OCF growth 5YN/A